Predictors of proteinuria and renal failure among women with HIV infection.
about
Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM studyHuman Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining ConditionsEpidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patientsThe impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysisHIV and kidney diseases: 35 years of history and consequencesRole of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D studyPrevalence of proteinuria among HIV-infected children attending a tertiary hospital in Lagos, Nigeria.Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study.Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study.HIV-infected persons continue to lose kidney function despite successful antiretroviral therapyMicroalbuminuria predicts overt proteinuria among patients with HIV infectionPrevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: a cross-sectional study.Race and other risk factors for incident proteinuria in a national cohort of HIV-infected veterans.Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis.Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapineA chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans.Expert opinion on pharmacotherapy of kidney disease in HIV-infected patients.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfectionImpact of antiretroviral therapy on renal function among HIV-infected Tanzanian adults: a retrospective cohort study.Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factorsRelationships between renal parameters and serum and urine markers of inflammation in those with and without HIV infectionMicroalbuminuria in HIV infection.Clinical outcomes of a combined HIV and renal clinic.Predictors of impaired renal function among HIV infected patients commencing highly active antiretroviral therapy in Jos, Nigeria.An Increase in Serum Creatinine after Initiation of Fenofibrate in an HIV-Infected Individual: A Case Report and Review of the Literature.Renal failure in HIV-positive patients-a South African experienceAlbuminuria Is Associated with Traditional Cardiovascular Risk Factors and Viral Load in HIV-Infected Patients in Rural South Africa.Tenofovir is associated with increased tubular proteinuria and asymptomatic renal tubular dysfunction in Ghana.Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors.Renal abnormalities among HIV infected children at Muhimbili National Hospital (MNH)-Dar es Salaam, TanzaniaKidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study.Proteinuria is common among HIV patients: what are we missing?Pharmacotherapy for human immunodeficiency virus-associated nephropathy.Prevalence of proteinuria and elevated serum cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) studyAntiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection.HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy.Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease.Prevalence and predictors of chronic kidney disease in newly diagnosed human immunodeficiency virus patients in Owerri, Nigeria.
P2860
Q24635177-73A7737E-A45D-4860-BE44-14B2784B5CBCQ26740117-1973ECEF-A26C-4B85-BA32-1CE659E46880Q27009523-9DBFC84F-A11E-4220-B24D-EB23E5EE3602Q27489415-0E474A5B-23D0-459D-B261-3FBD5BE8C749Q28069641-009056ED-1526-4C70-85D9-F43619D80905Q28533843-A061C8CA-8793-40BF-A952-9F910477798AQ28545222-60824D42-867D-4F11-A23D-3154E116D37FQ30381197-B2FF4FF0-B731-4640-8050-5876B77FEBC7Q30983924-2A69329A-CCC0-47D9-9DDA-E1029528901AQ33435099-6C1FA992-4747-4888-A1BB-56DF193B1060Q33731258-DD8262DD-814A-4C8E-B24C-B33AE5CEDE28Q33941438-8D5677E2-3E56-48DC-B5CB-3AC9AA571708Q34001926-3818619F-8141-4820-8648-72B8AA789CB0Q34173588-4C073F0C-5B18-48A1-BA39-5239F7790067Q34206774-472DCFA0-8EF7-409C-8879-132629854782Q34250879-5A42303B-9588-4B7F-8E3E-920282779668Q34301401-92330D59-02AD-4F6D-9A5F-D97ADFEC388AQ34686870-59FEDE25-FE98-47A3-9C74-0D7ADCACD148Q34736194-BE74A2E5-21F2-4D96-AEE1-633E460ABAC3Q35006740-B59C73A4-AC1A-4CE1-981A-6109CC2B4F87Q35107651-DC26ECDE-154B-4B99-8563-A99FC438D9B6Q35206635-C25C0EEE-FB0C-4F62-A740-DA35AA43B0B5Q35230397-136E7EA7-2E4C-4F75-8CD7-FB0FF14D2B2DQ35293817-F54C29B2-6F6B-4636-8113-F4E6948515F4Q35453074-55A5395F-C2AF-494A-A799-41319E0636A1Q35542976-81F58821-F9C6-4C70-8B62-545AB3871414Q35569823-41A592D9-9ADE-45CC-901E-4FBB1E9A424BQ35626495-46B73C43-A11C-4E33-9D4C-6C904349D23DQ35756256-90EEC825-F1C3-458F-A435-0D12890712CAQ35858002-48406897-A95D-4AEF-BED6-A787221D7936Q35883947-F3B0A7EE-46B3-4680-B3CF-76C67F90ABF8Q35965079-BF2163D3-B063-4E9C-933F-C38FDF2539DBQ36024460-07DD01D3-5793-499E-8468-97D59F037F2FQ36150549-7D6CC09C-C01D-45BD-9EC5-511CA1BCC286Q36320626-59561D1E-F8B3-41CD-B017-E52BAB2799E3Q36388998-1DC01DE6-1B6D-45BB-857C-AF678B175264Q36407276-B576125C-AEFC-40D7-8E18-0629F9D9901CQ36451062-CC30BE57-FAE4-4060-AA42-F8C6E0845077Q36486076-0375C531-716B-41F5-95C7-D6D1B65B6491Q36580386-47A66A35-7C13-4A70-B26D-0DD0AF1D214A
P2860
Predictors of proteinuria and renal failure among women with HIV infection.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Predictors of proteinuria and renal failure among women with HIV infection.
@en
type
label
Predictors of proteinuria and renal failure among women with HIV infection.
@en
prefLabel
Predictors of proteinuria and renal failure among women with HIV infection.
@en
P2093
P1433
P1476
Predictors of proteinuria and renal failure among women with HIV infection.
@en
P2093
John A Bartlett
Kathryn Anastos
Laura P Svetkey
Lynda Anne Szczech
Mardge H Cohen
Mary Young
Preston S Klassen
P304
P356
10.1046/J.1523-1755.2002.00094.X
P407
P577
2002-01-01T00:00:00Z
P5875
P6179
1038061557